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Many personal care products on the market contain endocrine disrupting chemicals, including parabens. Parabens are 
well known chemical additives used as preservatives. They have been found in mammary glands and breast cancer tissues. 
At the same time, the general public is increasingly exposed to plastic micro- and nanoparticles generated during plastic 
production and waste disposal. Exposure to chemical cocktails is a realistic scenario of high public health interest, in 
which many types of compounds such as these two may exhibit synergistic or additive adverse effects. This study evaluated 
the effects of plastic nanoparticles, parabens, and their mixture on the viability and proliferation of two human breast 
cancer cell lines: MDA-MB 231, which lacks oestrogen receptors, and MCF-7, which expresses these receptors. Parabens 
increased proliferation of oestrogen-sensitive breast cancer cells, and this effect became synergistic in the presence of 
plastic nanoparticles. The mechanism behind synergy may be related to the translocation and adsorption properties of 
nanoplastics, which served as a Trojan horse to expose cells to parabens more efficiently. These preliminary findings 
support growing evidence warning about the urgent problem of human exposure to combinations of plastic waste and 
contingent chemicals.
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Even though European Chemical Agency’s regulation 
REACH (1) has done a lot to improve the protection of 
human health and the environment from the risks posed by 
chemicals, about 30 % still does not comply to this 
regulation. Among them, of particular concern are endocrine 
disrupting chemicals (EDCs), defined by the World Health 
Organization (WHO) as “exogenous substances or mixtures 
that influence the endocrine system and cause adverse health 
effects in an intact organism, or its progeny, or (sub) 
populations” (3). Little is still known about the presence of 
EDCs in consumer products and exposure levels for the 
general population. To address this issue, the European 
Commission has recently published a communication on 
EDCs, announcing intention to establish a horizontal 
approach to identifying EDCs across all relevant EU 
legislation (4). At the same time, Health and Environment 
Alliance calls for an urgent EU action plan to save billions 
of euros in health-related costs on yearly basis (5). Until 
well-defined and clear action plan on EDCs is delivered, 
the only relevant tool to be employed for regulating EDCs 
is the precautionary principle, which should be based on 
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early warnings, as highlighted by the European Environment 
Agency (6).
The most known and studied EDCs are phthalates, 
parabens, and bisphenol A, present in a wide range of 
products used by the general population, such as food, 
drinks, pharmaceuticals, personal care products, or 
packaging materials. Oestrogenic activity of parabens was 
first reported almost 20 years ago (7). Since then, a vast 
number of research has evidenced different modes of 
paraben action, including their ability to reach blood and 
different tissues, their binding affinity to oestrogen 
receptors, their potential to trigger the growth of oestrogen-
responsive breast cancer, or their impact on male 
reproductive function (8–11). Considering that most 
personal care products on the market contain parabens as 
preservatives, and that parabens have been found in 
mammary glands and breast cancer tissues (12), there is 
continuous interest to elucidate adverse outcome pathways 
of parabens or chemical mixtures containing them in 
humans (13).
Particular interest has been focused on realistic 
scenarios of exposure to chemical cocktails in which many 
types of EDCs act together with other types of chemicals 
(9). One such scenario is exposure to plastic debris that 
originates from plastic waste. This is an alarming 
environmental and health issue in itself, but also from the 
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hormone-disrupting point of view, as most plastics release 
EDCs (14). Enormous global production and use of plastics 
has been responsible for the pollution of environment with 
tens of millions of tonnes of plastic waste that gradually 
degrades into micro- and nanoparticles (15). Recent reports 
estimate that trillions of plastic particles lie on the surface 
of the oceans (16). Humans are exposed to these plastic 
micro- or nanoparticles through different routes such as 
food, drinking water, or personal care products of cosmetic 
industry, which contain plastic particles by design (17). The 
aim of this study, preliminary in its character, was therefore 
to evaluate the effects of parabens and plastic nanoparticles, 
separately and in combination, on the viability and 
proliferation of two cell lines derived from human breast 
adenocarcinoma: the highly aggressive and poorly 
differentiated MDA-MB 231, which lacks HER2, 
progesterone, and oestrogen receptors, and MCF-7, a more 
differentiated cell line, morphologically similar to 
mammary epithelium, which expresses progesterone 
receptor and oestrogen receptor alpha (ERα). The cells were 
treated with polystyrene nanoparticles (PSNP) or a mixture 
of methyl-, ethyl, propyl- and butylparaben (PBmix), or a 
cocktail of PSNP and PBmix. The choice of both was based 
on the plethora of already published findings of their 
separate action in vitro. With our preliminary data we hoped 
to complement the existing early warnings about the urgent 




Dulbecco’s Modified Eagle’s Medium (DMEM), 
phosphate-buffered saline (PBS), bovine serum albumin 
(BSA), Triton X-100, ethanol, methylparaben, ethylparaben, 
n-propylparaben, and n-butylparaben were obtained from 
Sigma Chemical Co. (Darmstadt, Germany). Foetal bovine 
serum (FBS, heat inactivated), penicillin, streptomycin, and 
trypsin-EDTA were obtained from PAA Laboratories GmbH 
(Colbe, Germany). Stock solution of the paraben mixture 
was prepared by dissolving each paraben in absolute ethanol 
at the final concentration of 100 µg/mL. The final 
concentration of ethanol in the medium for each paraben 
was not above 0.2 %. At this concentration, ethanol has no 
effect on cell viability and proliferation. Plastic nanoparticles 
(PSNP) were purchased from ThermoFisher Scientific 
(Waltham, MA, USA) as 60 nm polystyrene nanosphere 
size standards.
CellTiter 96® AQueous One Solution Cell Proliferation 
Assay (MTS) from Promega (Madison, WI, USA) was used 
for colorimetric determination of the number of viable cells 
after treatment with PSNP and PBmix. Cell proliferation 
was quantified with a Muse® Ki67 Proliferation Kit 
(Luminex Corporation, Madison, WI, USA).
Cell cultures
MDA-MB 231 and MCF-7 cell lines (ATCC, City of 
Manassas, VA, USA) were cultured in T75 culture flasks 
(Eppendorf, Hamburg, Germany) in DMEM supplemented 
with 10 % BSA and 1 % of penicillin/streptomycin until 
they reached 80 % confluence. Cell culture medium was 
then removed and cells rinsed with sterile PBS, after which 
they were detached by adding 0.25 % trypsin-EDTA 
solution and incubated at 37 °C and 5 % CO2
 for 5 min. 
Detached cells were collected and counted on a TC20 
automated cell counter (BioRad, Hercules, CA, USA) and 
then plated in clear 96-well plates (Eppendorf, Hamburg, 
Germany) at a density of 10,000 cells per well for the cell 
viability assay or in clear 6-well plates at a density of 50,000 
cells per well for the cell proliferation assay. Plates were 
then incubated at 37 °C and 5 % CO2 for 24 h to allow cell 
attachment. The following day, culture medium was 
removed from the wells and replaced with a fresh one. Cells 
were then treated with PBmix, PSNP, or the PBmix + PSNP 
cocktail. The final tested concentrations in the wells were 
1, 10, and 100 µg/mL for PSNP and 0.01, 0.1, and 1 µg/mL 
for the PBmix. The PSNP + PBmix cocktails contained the 
same concentrations of the two components as described 
above.
For the viability assay we used two controls. The 
positive control consisted of cells treated with 1 % Triton 
X-100 and the negative control of cells treated with sterile 
PBS (PSNP solvent) and ethanol (PBmix solvent) in the 
same volumes that were used for PSNP or PBmix treatment.
For the proliferation assay, cells treated with 10 % 
DMSO served as positive control for inhibited cell 
proliferation (without complete cell disintegration as with 
Triton X-100) and negative controls were the same as in 
the viability assay.
Plates were then incubated at 37 °C and 5 % CO2 for 
24 h for the viability (MTS) assay and for 120 h for the 
proliferation (Ki67) assay.
Cell viability assay
Metabolic activity in treated cells was determined with 
the CellTiter 96® AQueous One Solution Cell Proliferation 
Assay, which is based on the reduction of the yellow 
tetrazolium salt MTS ([3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium) to formazan. The amount of produced 
formazan was measured by light absorbance at 490 nm on 
a spectrophotometer, and is proportional to the number of 
viable cells. MDA-MB 231 and MCF-7 cells were plated 
and treated as described above. At the end of 24 h treatment, 
the medium from each well was removed by aspiration and 
cells were washed three times with 200 μL of PBS per well. 
Fresh culture medium was then added, followed by MTS 
reagent solution. After 3 h of incubation at 37 °C and 5 % 
CO2, absorbance was read at 490 nm on a Victor 3 
Multilabel Plate Reader (PerkinElmer Inc., Waltham, MA, 
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*100 %) to obtain the percentages of 
cell viability for each treatment group, expressed as means 
and standard deviations (mean ± SD).
Proliferation assay
Proliferation of MDA-MB 231 and MCF-7 cells was 
quantified with a Muse® Ki67 Proliferation Kit. The 
percentage of proliferating cells was determined by 
fluorescent labelling of the Ki-67 protein, a nuclear antigen 
used as a marker of proliferation. Cells were plated and 
treated with PSNP or PBmix as described above, after which 
they were incubated at 37 °C and 5 % CO2 for 5 days. After 
incubation, culture medium was removed from the wells, 
cells washed twice with sterile PBS, and 0.25 % trypsin-
EDTA solution added to detach the cells. After 5 min of 
incubation at 37 °C and 5 % CO2, fresh culture medium 
was added to inactivate trypsin, and cells collected in 2 mL 
Eppendorf tubes. Cells were then labelled using the Ki67 
Proliferation Kit according to manufacturer’s instructions 
and were acquired on Muse Cell Analyzer (Luminex 
Corporation, Madison, Wisconsin, USA). Unstained control 
cells were used for gating to determine the percentage of 
proliferating, Ki67-positive cells in the samples. Means and 
standard deviations were calculated from percentages of 
viability. Percentages of proliferating (Ki67 positive) cells 
were used to calculate means ± SD for each treatment.
Statistical analysis
For statistical analysis we used the GraphPad Prism 6.0 
software (San Diego, CA, USA) to run one-way ANOVA 
followed by Dunnett’s multiple comparison test to compare 
mean values of individual treatments with control means. 
Significance threshold was set at P<0.05.
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RESULTS AND DISCUSSION
Cell viability results (Figure 1) showed a dose-
dependent drop in the cell viability of MDA-MB 231 cells 
treated separately with PBmix or PSNPs or their 
combination. Although this drop crossed the threshold of 
statistical significance in all combined treatments, only the 
treatment with 1 µg/mL PBmix combined with 10 or 
100 µg/mL PSNPs resulted in viability loss above 80 %, 
which is conventionally considered the biologically 
significant threshold. Therefore, only the PBmix + PSNP 
cocktail was able to significantly decrease cell viability of 
MDA-MB 231 cells. However, this was not a clear sign of 
their cytotoxicity, as we did not measure the number of dead 
cells or establish the mechanism of cell death, but focused 
on the number of metabolically active cells.
In contrast, MCF-7 cells showed a consistent increase 
in cell viability when treated separately with PSNP or 
PBmix, as well as with the combination of 0.01 µg/mL PBs 
+ 100 µg/mL PSNP. Higher concentrations of PBmix or 
PSNP in the combination did not induce any significant 
changes in cell viability. These results point to the possibility 
of stimulated cell proliferation, which was further explored 
with the Ki-67 assay.
Cell proliferation findings underscore the differences 
between MCF-7 and MDA-MB 231 cells in response to 
combined PBmix + PSNP treatment (Figure 2). The 
percentages of proliferating (Ki67-positive) MDA-MB 231 
cells dropped in all treatments (PBmix, PSNP, and 
PBmix + PSNP cocktails) compared to control cells, but 
the drop was significant only for the PBmix concentration 
of 1 µg/mL. As in cell viability, MCF-7 cells again showed 
opposite findings, that is, a dose-dependent increase in cell 
proliferation after treatment with PBmix, but this increase 
was not significant. Treatment with PSNPs alone did not 
Figure 1 Effects of parabens (PB) and/or polystyrene nanoparticles (PSNP) on breast cancer cell viability. * significantly different 
(P<0.05) from negative control
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increase cell proliferation compared to controls. Considering 
the differences in cell surface receptors between the two 
cell lines and the well-known interactions between parabens 
and oestrogen receptors, these results were expected.
The most interesting findings were obtained with the 
PBmix + PSNP combinations. The percentages of 
proliferating (Ki67-positive) cells increased significantly 
and more than doubled at the highest PSNP concentrations, 
irrespective of the PBmix concentrations (Figure 2). These 
observations indicated that the proliferation activity of 
PBmix in oestrogen-sensitive breast cancer cells was 
synergistically driven by the presence of PSNP. A 
mechanism that stands behind it could be related to the 
translocation and adsorption properties of PSNP, acting like 
a Trojan horse to expose cells to parabens more efficiently. 
Exposure to a chemical cocktail such as this is therefore 
expected to promote proliferation of oestrogen-sensitive 
cells and greatly contribute to the development of breast 
cancer.
CONCLUSION
This preliminary study warns against the risks of 
synergistic effects of chemical cocktails containing plastics 
nanoparticles and EDCs on proliferation of human breast 
cancer cells, which calls for a clearly defined action plan 
for risk management of EDCs and plastic waste at the global 
level. Risk assessment of exposure to chemical mixtures 
reflects real-life scenarios, but experimental evaluation of 
all possible combinations is almost impossible. Our 
knowledge may therefore benefit from simulating these 
combinations with advanced mathematical and statistical 
models based on results obtained for simpler mixtures. To 
achieve this objective, more research is needed to unveil 
the mechanisms behind mixture effects and to carefully 
consider all types of chemicals that should be included in 
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Sinergistički učinak parabena i nanoplastike na proliferaciju humanih stanica raka dojke
Većina proizvoda za osobnu njegu na tržištu sadrži kemikalije koje remete rad endokrinoga sustava kao što su parabeni. 
Primjena takvih proizvoda povećava izloženost opće populacije takvim kemikalijama. Parabeni, dobro poznati aditivi 
koji se koriste kao konzervansi, otkriveni su u mliječnim žlijezdama i tkivima raka dojke. Osim takvih kemikalija, 
izloženost plastičnim mikro- i nanočesticama koje nastaju tijekom proizvodnje, uporabe i odlaganja plastičnog otpada 
velik su zdravstveni i okolišni problem koji treba hitno rješavati. Za pouzdanu procjenu rizika za ljudsko zdravlje, nužno 
je objasniti ne samo učinke pojedinačnih kemijskih spojeva nego i njihovih mješavina. Istraživanje izloženosti kemijskim 
koktelima može pružiti podatke o mogućem sinergističkom ili aditivnom učinku kemikalija u takvim koktelima. Cilj 
ovoga istraživanja bio je procijeniti učinak plastičnih nanočestica, parabena i njihovih koktela na vijabilnost i proliferaciju 
dviju različitih stanica karcinoma dojke: stanične linije MDA-MB 231 kojoj nedostaju estrogeni receptori i MCF-7 stanica 
koje izražavaju te receptore. Dobiveni rezultati pokazali su da ni parabeni ni plastične nanočestice, primijenjeni posebno, 
u ispitivanim koncentracijskim rasponima nisu značajnije promijenili vijabilnost i proliferacijsku aktivnost u stanicama 
karcinoma dojke. Međutim, parabeni su pojačali proliferacijsku aktivnost stanica osjetljivih na estrogene koja je sinergistički 
potaknuta prisutnošću plastičnih nanočestica. Mehanizam takva djelovanja može biti povezan s translokacijskim i 
adsorpcijskim svojstvima nanočestica, koje su poslužile kao vektor za učinkovitije izlaganje stanica parabenima. 
Protumorska aktivnost na karcinomu dojke može se očekivati kao konačni ishod izloženosti takvom kemijskom koktelu. 
Ovi preliminarni podatci dragocjeni su dodatak postojećim ranim upozorenjima na novi problem s povećanjem izloženosti 
ljudi plastičnom otpadu i kemijskim kemikalijama.
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